Mammalian, plant, and gut microbiota-derived extracellular vesicles as emerging therapeutics for bone diseases
Frontiers in Bioengineering and Biotechnology · 08.05.2026 · 14
DOI: 10.3389/fbioe.2026.1825617 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioengineering and Biotechnology, online erschienen am 08.05.2026. Verfasst von Guanchen Yin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bone and Joint Surgery, Orthopaedic Surgery Center, The First Hospital of Jilin University, Changchun, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 125 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Bone disorders, including osteoporosis and osteoarthritis, represent a growing global health burden, yet current therapies remain limited by poor targeting efficiency and significant adverse effects. Extracellular vesicles (EVs), nanoscale lipid bilayer particles that mediate intercellular communication, have emerged as promising endogenous nanocarriers with intrinsic biocompatibility and regulatory capacity. This review summarises recent advances in EVs-based therapeutic strategies for bone diseases, focusing on EVs derived from mammalian cells, plants, and the gut microbiota. Particular emphasis is placed on gut microbiota-derived EVs, which have gained increasing attention for their role in regulating bone homeostasis through the “gut-bone axis”. By comparing the biological characteristics, advantages, limitations, and disease-specific applicability of EVs from these distinct sources, we highlight their complementary therapeutic potential. Overall, this review provides a concise framework for the rational development and clinical translation of EVs-based precision therapies for bone disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Bone and Joint Surgery, Orthopaedic Surgery Center, The First Hospital of Jilin University, Changchun, China.
- Department of Orthopedics, Yantai Yantaishan Hospital, Yantai, China.
Zitieren
APA
Yin, G., Wang, H., Liu, Y., Wang, Z., Lin, X., Cheng, Q., & Gao, H. (2026). Mammalian, plant, and gut microbiota-derived extracellular vesicles as emerging therapeutics for bone diseases. Frontiers in Bioengineering and Biotechnology, 14. https://doi.org/10.3389/fbioe.2026.1825617
Vancouver
Yin G, Wang H, Liu Y, Wang Z, Lin X, Cheng Q, et al. Mammalian, plant, and gut microbiota-derived extracellular vesicles as emerging therapeutics for bone diseases. Frontiers in Bioengineering and Biotechnology. 2026;14. doi:10.3389/fbioe.2026.1825617
BibTeX
@article{Yin2026,
author = {Yin, Guanchen and Wang, Hao and Liu, Yi and Wang, Zhenyan and Lin, Xu and Cheng, Qisheng and Gao, Hang},
title = {Mammalian, plant, and gut microbiota-derived extracellular vesicles as emerging therapeutics for bone diseases},
journal = {Frontiers in Bioengineering and Biotechnology},
year = {2026},
volume = {14},
doi = {10.3389/fbioe.2026.1825617}
}
EUVIMED